FDA Advisory Panel Backs New Lupus Drug Benlysta

At the end of a day of often emotional testimony, an FDA advisory panel overwhelmingly voted to recommend the approval of a new drug for the treatment of systemic lupus.

See the article here:

FDA Advisory Panel Backs New Lupus Drug Benlysta

Posted by on November 17, 2010. Filed under Health, News. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry